Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study
暂无分享,去创建一个
E. Darai | F. Bertucci | R. Rouzier | P. Colombo | F. Reyal | C. Coutant | P. Gimbergues | N. Chopin | G. Houvenaeghel | A. Gonçalves | X. Muracciole | C. Zemmour | J. Boher | R. Villet | E. Lambaudie | R. Sabatier | J. Classe | L. Sabiani | Monique Cohen | S. Giard | J. Garbay | A. de Nonneville | C. Scherer